BIOMARIN
LIVE

Serial Number

78738394

Owner

Biomarin Pharmaceutical Inc.

Attorney

GREGORY J. CHINLUND

First Use Date

Nov 30, 2004

Filing Date

Oct 21, 2005

Add to watchlist:

No watchlists yet
View on USPTO

BIOMARIN Trademark

Serial Number: 78738394 • Registration: 3192347

BIOMARIN is a trademark filed by Biomarin Pharmaceutical Inc. on October 21, 2005. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Biomarin Pharmaceutical Inc. (99 trademarks)

371 Bel Marin Keys Blvd., Suite 210
Novato, CA 94949

Entity Type: 03

Trademark Details

Filing Date

October 21, 2005

Registration Date

January 2, 2007

First Use Anywhere

November 30, 2004

First Use in Commerce

November 30, 2004

Published for Opposition

October 17, 2006

Goods & Services

[ Assays and diagnostic screening kits composed primarily of reagents for scientific analysis and research for diagnosis of disorders and physiological processes and for measurement of disease markers for scientific purposes ]

Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders; [ pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceuticals for treatment of inflammation, infectious diseases and cardiovascular diseases; ] assays and diagnostic screening kits composed primarily of reagents for clinical and medical use for analysis and diagnosis of disorders and physiological processes and for measurement of disease markers for medical purposes; carbohydrate inhibiting enzymes for use in disease treatment; [ fungal lytic enzymes for the treatment of fungal infections; ] pharmaceuticals for treatment of lysosomal storage diseases; pharmaceuticals for treatment of mucopolysaccharidoses; pharmaceuticals for treatment of carbohydrate-inhibiting enzyme disorders; [ proteins and enzymes for the production, purification and isolation of biologics for use in the treatment of medical conditions; ] biologics produced by recombinant DNA technology for use in the treatment of pathological medical conditions

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 2, 2026 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Apr 26, 2016 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Apr 26, 2016 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 26, 2016 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 26, 2016 APRE
TEAS SECTION 8 & 9 RECEIVED
Feb 17, 2016 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 2, 2016 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 30, 2012 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 30, 2012 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 29, 2012 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 2, 2012 E815
REGISTERED-PRINCIPAL REGISTER
Jan 2, 2007 R.PR
PUBLISHED FOR OPPOSITION
Oct 17, 2006 PUBO
NOTICE OF PUBLICATION
Sep 27, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 23, 2006 PREV
ASSIGNED TO LIE
Aug 18, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2006 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 11, 2006 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 11, 2006 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 11, 2006 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 12, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 12, 2006 TROA
NON-FINAL ACTION E-MAILED
May 2, 2006 GNRT
NON-FINAL ACTION WRITTEN
May 2, 2006 CNRT
ASSIGNED TO EXAMINER
Apr 25, 2006 DOCK
NEW APPLICATION ENTERED
Oct 25, 2005 NWAP